Skip to search formSkip to main contentSkip to account menu

Leishmaniasis Vaccine

Known as: Leishmania Vaccines, Leishmaniasis Vaccines, Vaccines, Leishmania 
Vaccines or candidate vaccines used to prevent infection with LEISHMANIA.
National Institutes of Health

Related topics

Related topics

8 relations
In BloodProcess of secretionagonistsantagonists & inhibitors

Narrower (1)

autoclaved Leishmania major vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Immunity and immunosuppression in experimental visceral leishmaniasis.
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner… 
Review
1998
Review
1998
T lymphocyte differentiation in the periphery.
Highly Cited
1995
Highly Cited
1995
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Infection of mice with the protozoan Leishmania major is an established in vivo model for the definition of factors that… 
Highly Cited
1994
Highly Cited
1994
Role and effect of TNF-alpha in experimental visceral leishmaniasis.
TNF-alpha has been implicated in cytokine-induced macrophage activation and tissue granuloma formation, two activities linked to… 
Highly Cited
1993
Highly Cited
1993
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
The lymphokine profiles were determined in the skin lesions of the three distinct clinical forms of American cutaneous… 
Highly Cited
1991
Highly Cited
1991
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages
Inbred strains of mice differ considerably in their innate resistance to leishmanial infection. BALB/c mice are highly… 
Highly Cited
1990
Highly Cited
1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.
Review
1989
Review
1989
Functional heterogeneity of CD4+ T cells in leishmaniasis.
Highly Cited
1987
Highly Cited
1987
Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor.
The major cell surface glycoconjugate of Leishmania major, a putative parasite receptor for macrophages, is a lipophosphoglycan… 
Highly Cited
1983
Highly Cited
1983
Effectiveness of leishmanization in the control of cutaneous leishmaniasis.
To find out the effectiveness of leishmanization in the control of zoonotic cutaneous leishmaniasis, more than 250 persons were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)